[HTML][HTML] Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ
O Solís, J Addae, R Sweeting, I Meszoely… - Breast Cancer Research …, 2024 - Springer
Purpose Recent studies have established the safety and efficacy of Superparamagnetic Iron
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ
O Solís, J Addae, R Sweeting, I Meszoely… - … cancer research and … - pubmed.ncbi.nlm.nih.gov
Purpose Recent studies have established the safety and efficacy of Superparamagnetic Iron
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ.
O Solís, J Addae, R Sweeting, I Meszoely… - … Cancer Research and …, 2024 - europepmc.org
Purpose Recent studies have established the safety and efficacy of Superparamagnetic Iron
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …